Literature DB >> 15661557

Association of CK19 mRNA detection of occult cancer cells in mediastinal lymph nodes in non-small cell lung carcinoma and high risk of early recurrence.

Françoise Le Pimpec-Barthes1, Claire Danel, Roger Lacave, Sylvie Ricci, Xavier Bry, Frédérique Lancelin, Cécile Leber, Bernard Milleron, Jocelyne Fleury-Feith, Marc Riquet, Jean-François Bernaudin.   

Abstract

This study was designed to screen occult cancer cells by CK19 mRNA detection using reverse transcriptase-polymerase chain reaction (RT-PCR) in mediastinal lymph nodes stations (MLNS) in non-small cell lung carcinoma (NSCLC). In 49 NSCLC patients free of mediastinal adenopathy on computed tomograph, 254 MLNS were evaluated by histopathology, immunohistochemistry (IHC) and RT-PCR. Of 225 non-tumoral MLNS on histopathology, 32 (14.2%) were positive by RT-PCR. IHC did not provide significant additional results. Seventeen patients were without mediastinal tumoral extension on histopathology and RT-PCR (Group 1), 16 were upgraded by RT-PCR (Group 2) and 16 pN2 on histopathology (Group 3). The two-year cancer-related death survival in Groups 1 (100%) and 2 (64.5%) was significantly different (P=0.04). The relative risk of recurrence in Group 2 compared with Group 1, evaluated by the Cox model multivariate analysis, was 5.61 (P=0.02). In conclusion, CK19 mRNA detected by RT-PCR in MLNS was significantly associated with an increased risk of rapid recurrence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661557     DOI: 10.1016/j.ejca.2004.09.021

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

1.  Detection of disseminated lung cancer cells in regional lymph nodes by assay of CK19 reverse transcriptase polymerase chain reaction and its clinical significance.

Authors:  Ming Jian Ge; Qing Chen Wu; Mei Wang; Yu Hong Zhang; Liang Bin Li
Journal:  J Cancer Res Clin Oncol       Date:  2005-07-27       Impact factor: 4.553

2.  Occult pN2 disease in lung cancer patients: a wide range of diseases endangering the long term prognosis.

Authors:  Marc Riquet; Ciprian Pricopi; Giuseppe Mangiameli; Alex Arame; Alain Badia; Françoise Le Pimpec Barthes
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

3.  Serum vascular endothelial growth factor levels in patients with non-small cell lung cancer and its relations to the micrometastasis in peripheral blood.

Authors:  Yang Jin; Xianzhi Xiong; Yuan Su; Jianwu Hu; Xiaonan Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

Review 4.  Recurrence after surgery in patients with NSCLC.

Authors:  Hidetaka Uramoto; Fumihiro Tanaka
Journal:  Transl Lung Cancer Res       Date:  2014-08

5.  Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy.

Authors:  Chun-Chao Chang; Shung-Haur Yang; Chih-Cheng Chien; Shu-Hung Chen; Shiann Pan; Chia-Long Lee; Chih-Ming Lin; Hsiao-Lun Sun; Chi-Cheng Huang; Yih-Yiing Wu; Ruey-Neng Yang; Chi-Jung Huang
Journal:  BMC Cancer       Date:  2009-10-22       Impact factor: 4.430

6.  Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.

Authors:  J Li; Z-N Li; L-C Yu; S-B Shi; L-P Ge; J-R Wu; Y-M Hu
Journal:  Clin Transl Oncol       Date:  2013-02-12       Impact factor: 3.405

7.  Detection of occult carcinomatous diffusion in lymph nodes from head and neck squamous cell carcinoma using real-time RT-PCR detection of cytokeratin 19 mRNA.

Authors:  L Tao; M Lefèvre; S Ricci; P Saintigny; P Callard; S Périé; R Lacave; J-F Bernaudin; J Lacau St Guily
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

8.  Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer.

Authors:  Min Cheng; Yongyan Chen; Xiaoqing Yu; Zhigang Tian; Haiming Wei
Journal:  BMC Cancer       Date:  2008-05-31       Impact factor: 4.430

9.  Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer.

Authors:  Ane Kongsgaard Rud; Kjetil Boye; Øystein Fodstad; Siri Juell; Lars H Jørgensen; Steinar Solberg; Åslaug Helland; Odd Terje Brustugun; Gunhild Mari Mælandsmo
Journal:  Diagn Pathol       Date:  2016-06-17       Impact factor: 2.644

Review 10.  [The prognostic value of micrometastasis in non-small cell lung cancer].

Authors:  Yuanyuan Lei; Yilong Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.